We are live on
!
Find out more
SCM
Sio Capital Management Portfolio holdings
AUM
$697M
1-Year Est. Return
79.73%
This Fund
S&P 500
This Quarter
Est. Return
+12.64%
1 Year Est. Return
+79.73%
3 Year Est. Return
+576.62%
5 Year Est. Return
+422.76%
10 Year Est. Return
+2,506.65%
AUM
$393M
AUM Growth
+$191M
(+94%)
Cap. Flow
+$179M
Cap. Flow
% of AUM
45.64%
Top 10 Holdings %
Top 10 Hldgs %
69.35%
Holding
62
New
18
Increased
13
Reduced
5
Closed
15
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
GE HealthCare
GEHC
|
+$32.2M |
| 2 |
Labcorp
LH
|
+$32M |
| 3 |
GSK
GSK
|
+$17.2M |
| 4 |
Globus Medical
GMED
|
+$8.27M |
| 5 |
PDCO
Patterson Companies, Inc.
PDCO
|
+$6.75M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Centene
CNC
|
+$27.4M |
| 2 |
Cencora
COR
|
+$20.5M |
| 3 |
Medtronic
MDT
|
+$6.77M |
| 4 |
Avantor
AVTR
|
+$5.99M |
| 5 |
Relay Therapeutics
RLAY
|
+$3.79M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 71.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ELEV
51
DELISTED
Elevation Oncology
ELEV
| – | – |
-876,611
| Closed | -$1.67M |
|
|
52
Medtronic
MDT
$111B
| – | – |
-84,012
| Closed | -$6.77M |
|
|
MRUS
53
DELISTED
Merus
MRUS
| – | – |
-15,564
| Closed | -$286K |
|
54
Pharvaris
PHVS
$2.25B
| – | – |
-228,385
| Closed | -$1.84M |
|
|
55
Relay Therapeutics
RLAY
$4.04B
| – | – |
-230,013
| Closed | -$3.79M |
|
56
Revolution Medicines
RVMD
$38.8B
| – | – |
-125,957
| Closed | -$2.73M |
|
57
Spyre Therapeutics
SYRE
$8.27B
| – | – |
-120,198
| Closed | -$871K |
|
|
SIEN
58
DELISTED
Sientra, Inc.
SIEN
| – | – |
-254,997
| Closed | -$393K |
|
|
EUCRU
59
DELISTED
Eucrates Biomedical Acquisition Corp. Unit
EUCRU
| – | – |
-248,674
| Closed | -$2.58M |
|
|
NVCN
60
DELISTED
Neovasc Inc.
NVCN
| – | – |
-22,537
| Closed | -$657K |
|
|
CTIC
61
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
| – | – |
-526,239
| Closed | -$2.21M |
|
|
HSKA
62
DELISTED
Heska Corp
HSKA
| – | – |
-17,450
| Closed | -$1.7M |
|
Similar funds
GUB
KLI
JA
WIC
AAM
TCM
CA
SAM
Sio Capital Management's Q2 2023 Portfolio in Review
As of Q2 2023, Sio Capital Management held 62 positions worth $393M, up 94% from $202M the previous quarter. Its ten largest holdings account for 69% of the portfolio.
Sio Capital Management deployed $179M of net new capital in Q2 2023, opening 18 new positions and adding to 13 existing holdings. Its largest new stake was Labcorp: 165,179 shares worth $34.2M.
By sector, the portfolio is most concentrated in Healthcare at 71% of assets, down from 99% a quarter earlier.
On the sell side, the largest reduction was Repare Therapeutics, an estimated $1.57M trimmed.
- Sio Capital Management's largest Q2 2023 buy was Labcorp: 165,179 shares worth $34.2M.
- Sio Capital Management added most to GE HealthCare in Q2 2023, an estimated $32.2M increase.
- Sio Capital Management's biggest Q2 2023 reduction was Repare Therapeutics, cutting an estimated $1.57M.
- Sio Capital Management fully exited Centene in Q2 2023, selling an estimated $27.4M.
- Sio Capital Management's ten largest holdings make up 69% of its $393M portfolio in Q2 2023.
- Sio Capital Management opened 18 new positions and closed 15 in Q2 2023.
- Sio Capital Management's portfolio value rose 94% quarter-over-quarter to $393M.
Based on Sio Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.